Vemurafenib for BRAFV600E-positive metastatic papillary thyroid cancer.
Department of Medical Oncology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France. Electronic address: olivier.huillard@aphp.fr.
Olivier
O
Huillard
Department of Nuclear Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.
Florence
F
Tenenbaum
Department of Nuclear Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.
Jerome
J
Clerc
Department of Medical Oncology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.
Francois
F
Goldwasser
Department of Endocrinology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.
Lionel
L
Groussin
D006801:Humans; D007211:Indoles; D048493:Proto-Oncogene Proteins B-raf; D013449:Sulfonamides; D013964:Thyroid Neoplasms; D000077484:Vemurafenib
D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib; D048493:Proto-Oncogene Proteins B-raf